Skip to Main Content

Paper Details

ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria.
Pediatr Nephrol
4
2023
Author NameAffiliation
Edward R GouldVanderbilt University Hospital
  • 1 - 1

Datasets

Release 1.2